Packer, M., Cleland, J. G.F. and Bauersachs, J. (2024) Great debate: SGLT2 inhibitors should be first-line treatment in heart failure with reduced ejection fraction. European Heart Journal, 45(25), pp. 2186-2196. (doi: 10.1093/eurheartj/ehae300) (PMID:38805680)
![[img]](https://eprints.gla.ac.uk/style/images/fileicons/text.png) |
Text
330129.pdf - Accepted Version Restricted to Repository staff only until 28 May 2025. 232kB |
Abstract
No abstract available.
| Item Type: | Articles |
|---|---|
| Additional Information: | J.B. was supported by the Deutsche Forschungsgemeinschaft (KFO 311). |
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Cleland, Professor John |
| Authors: | Packer, M., Cleland, J. G.F., and Bauersachs, J. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
| Journal Name: | European Heart Journal |
| Publisher: | Oxford University Press |
| ISSN: | 1522-9645 |
| ISSN (Online): | 1522-9645 |
| Published Online: | 28 May 2024 |
| Copyright Holders: | Copyright © 2024 Oxfor University Press |
| First Published: | First published in European Heart Journal 45(25):2186-2196 |
| Publisher Policy: | Reproduced in accordance with the copyright policy of the publisher |
University Staff: Request a correction | Enlighten Editors: Update this record
Altmetric
Altmetric